CRISPR Therapeutics AG (CRSP) › EPS (Diluted)CRISPR Therapeutics AG (CRSP) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2017: $-1.712018: $-3.442019: $1.172020: $-5.292021: $4.702022: $-8.362023: $-1.942024: $-4.342025: $-6.47$-6.472017EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$-6.47-49.1%2024$-4.34-123.7%2023$-1.94+76.8%2022$-8.36-277.9%2021$4.70+188.8%2020$-5.29-552.1%2019$1.17+134.0%2018$-3.44-101.2%2017$-1.71—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share